CHF16.08
1.71%
SIX Swiss Exchange, Oct 21, 05:31 pm CEST. Closed.
ISIN
CH0042615283
Symbol
DOCM

DocMorris Target price 2026 - Analyst rating & recommendation

DocMorris Classifications & Recommendation

Buy
57%
Hold
43%

DocMorris Price Target

Target Price CHF11.73
Price CHF16.08
Deviation
Number of Estimates 8
8 Analysts have issued a price target DocMorris 2027 . The average DocMorris target price is CHF11.73. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 8 Analysts recommend DocMorris to buy, 6 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2027 of . Most analysts recommend the DocMorris stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Billion CHF ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

9 Analysts have issued a sales forecast DocMorris 2026 . The average DocMorris sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF1.1b 10.56%
2026
2027
2028
2029
2030

9 Analysts have issued an DocMorris EBITDA forecast 2026. The average DocMorris EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 CHF-53.5m 6.96%
2026
2027
2028
2029

EBITDA Margin

2025 -4.76% 15.84%
2026
2027
2028
2029

9 DocMorris Analysts have issued a net profit forecast 2026. The average DocMorris net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF-134m 38.20%
2026
2027
2028
2029
2030

Net Margin

2025 -11.95% 25.00%
2026
2027
2028
2029
2030

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share CHF ??? ???
??? ???
P/E ???
EV/Sales ???

9 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF-3.47 14.53%
2026
2027
2028
2029
2030

P/E ratio

Current -6.06 385.77%
2026
2027
2028
2029
2030

Based on analysts' sales estimates for 2026, the DocMorris stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.83 176.67%
2026
2027
2028
2029
2030

P/S ratio

Current 0.68 186.71%
2026
2027
2028
2029
2030

Current DocMorris Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today